Reliable in vitro studies require appropriate ovarian cancer cell lines

por Jacob, Francis, Nixdorf, Sheri, Hacker, Neville F, Heinzelmann-Schwarz, Viola A
Publicado 2014

High‐grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancer

por Jacob, Francis, Marchetti, Rosa Lina, Kind, André B., Russell, Kenneth, Schoetzau, Andreas, Heinzelmann‐Schwarz, Viola A.
Publicado 2020

The Wnt Gatekeeper SFRP4 Modulates EMT, Cell Migration and Downstream Wnt Signalling in Serous Ovarian Cancer Cells

por Ford, Caroline E., Jary, Eve, Ma, Sean Si Qian, Nixdorf, Sheri, Heinzelmann-Schwarz, Viola A., Ward, Robyn L.
Publicado 2013

Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells

por Jacob, Francis, Hitchins, Megan P, Fedier, André, Brennan, Kevin, Nixdorf, Sheri, Hacker, Neville F, Ward, Robyn, Heinzelmann-Schwarz, Viola A
Publicado 2014

A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker

por HEINZELMANN-SCHWARZ, VIOLA A., NIXDORF, SHERI, VALADAN, MEHRNAZ, DICZBALIS, MONICA, OLIVIER, JAKE, OTTON, GEOFF, FEDIER, ANDRÉ, HACKER, NEVILLE F., SCURRY, JAMES P.
Publicado 2014

Loss of Secreted Frizzled-Related Protein 4 Correlates with an Aggressive Phenotype and Predicts Poor Outcome in Ovarian Cancer Patients

por Jacob, Francis, Ukegjini, Kristjan, Nixdorf, Sheri, Ford, Caroline E., Olivier, Jake, Caduff, Rosmarie, Scurry, James P., Guertler, Rea, Hornung, Daniela, Mueller, Renato, Fink, Daniel A., Hacker, Neville F., Heinzelmann-Schwarz, Viola A.
Publicado 2012